Open-Access HMO

An Open-Access Health Maintenance Organization (HMO) is a type of managed care health insurance plan that combines some of the features of traditional HMOs with some of the features of Preferred Provider Organizations (PPOs). Here are some key features of Open-Access HMOs:

  • No primary care physician (PCP) requirement: Unlike traditional HMOs, which require members to choose a PCP who acts as a gatekeeper to specialty care, Open-Access HMOs allow members to seek care from any provider within the network without a referral.

  • No out-of-network coverage: Open-Access HMOs typically do not provide coverage for care received outside of the network, although emergency care is often an exception.

  • Lower out-of-pocket costs: Open-Access HMOs generally have lower out-of-pocket costs than PPOs, although they may have higher premiums.

  • Provider network limitations: While Open-Access HMOs do not require members to choose a PCP, they still have provider networks that members must stay within to receive care. Some Open-Access HMOs may have smaller networks than traditional HMOs.

Example: Let's say that a person is in the market for health insurance and is considering an Open-Access HMO. They would have the flexibility to see any provider within the network without a referral, but would need to stay within the network to receive coverage. They would also have lower out-of-pocket costs than a PPO, but may pay higher premiums.

In this example, the Open-Access HMO offers the person some of the benefits of a traditional HMO (such as lower out-of-pocket costs) and some of the benefits of a PPO (such as the ability to see any provider without a referral). However, the person would still be limited to the provider network within the plan, which may be smaller than traditional HMO networks.

Next Up

Welcome to our latest release. We are excited for you to try the new features.
According to Mployer Insights’ 2026 analysis of 50,000+ employer health plans, prescription drugs account for over 25% of total benefit expenses, with Tier 4 specialty drugs driving the majority of high-cost claims. While Tier 4 copays average $123 with coinsurance requirements in 31% of plans, individual oncology therapies like Darzalex Faspro ($170,800/yr) and Keytruda ($158,200/yr) frequently exceed average individual stop-loss deductibles ($141,938). To mitigate exposure, self-funded employers are increasingly turning to independent, transparent PBM models and biosimilar substitution—which yields up to a 73% net cost reduction per patient.
Most U.S. employers now offer paid maternity leave beyond the legal minimum, but coverage varies widely once you look past the basics. According to Mployer Insights' 2026 analysis of more than 50,000 employer benefit plans, 68% of employers provide paid maternity leave on top of short-term disability, typically adding 8 extra weeks, and half now cover 100% of salary during the disability period. Support drops off from there: only 41% of employers offer paid bonding leave for non-birth parents, and advanced family-building benefits remain even less common, with just 28% covering IVF and 11% offering adoption financial assistance. The data suggests that while baseline maternity leave has become standard, more comprehensive family-building support is still the exception rather than the norm.